Nexgel (NXGL) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to -$0.08.
- Nexgel's EPS (Weighted Average and Diluted) rose 2727.27% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year increase of 3728.81%. This contributed to the annual value of -$0.53 for FY2024, which is 538.23% up from last year.
- Per Nexgel's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.08 for Q3 2025, which was up 2727.27% from -$0.09 recorded in Q2 2025.
- In the past 5 years, Nexgel's EPS (Weighted Average and Diluted) ranged from a high of -$0.08 in Q3 2025 and a low of -$0.38 during Q3 2021
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.18, with a median of -$0.14 in 2024.
- The largest annual percentage gain for Nexgel's EPS (Weighted Average and Diluted) in the last 5 years was 7110.15% (2021), contrasted with its biggest fall of 370000.0% (2021).
- Nexgel's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.3 in 2021, then soared by 63.04% to -$0.11 in 2022, then crashed by 90.25% to -$0.21 in 2023, then skyrocketed by 39.53% to -$0.13 in 2024, then soared by 36.78% to -$0.08 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.08 in Q3 2025, compared to -$0.09 in Q2 2025 and -$0.09 in Q1 2025.